Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Protagonist Therapeutics Inc shares valued at $631,872 were sold by Ali Asif on Sep 11 ’24. At $44.49 per share, Ali Asif sold 14,203 shares. The insider’s holdings dropped to 34,960 shares worth approximately $1.61 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Waddill William D. sold 8,000 shares, netting a total of over 360,000 in proceeds. Following the sale of shares at $45.00 each, the insider now holds 12,000 shares.
Before that, Ali Asif had added 14,203 shares to its account. In a trade valued at $631,855, the Officer bought Protagonist Therapeutics Inc shares for $44.49 each.
As published in their initiating research note from Truist on September 09, 2024, Protagonist Therapeutics Inc [PTGX] has been a Buy and the price target has been revised to $60. Analysts at CapitalOne started covering the stock with ‘”an Overweight”‘ outlook in a report released in late October. Earlier on August 25, 2022, JMP Securities initiated its rating. Their recommendation was “a Mkt outperform” for PTGX stock.
Analyzing PTGX Stock Performance
During the last five days, there has been a surge of approximately 0.59%. Over the course of the year, Protagonist Therapeutics Inc shares have jumped approximately 100.26%. Shares of the company reached a 52-week high of $48.00 on 09/16/24 and a 52-week low of $21.43 on 01/05/24. A 50-day SMA is recorded $40.46, while a 200-day SMA reached $30.86. Nevertheless, trading volume fell to 0.65 million shares from 0.53 million shares the previous day.
Support And Resistance Levels for Protagonist Therapeutics Inc (PTGX)
According to the 24-hour chart, there is a support level at 45.13, which, if violated, would cause prices to drop to 44.34. In the upper region, resistance lies at 46.63. The next price resistance is at 47.34. RSI (Relative Strength Index) is 64.66 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 1.03, which suggests the price will increase in the coming days. Percent R is at 28.37%, indicating bullish price movement. Stochastics %K at holding indicates that the stock is to be held.
